Year: 2019
The U.S. workforce is dying younger. Why?
More CBD Education Required before we call CBD a Cure-all
I read a column in my local paper serving a community north of Boston of about 100,000 people recently where the columnist, who is an MD, extolled the virtues of CBD products in almost miracle drug proportion. I immediately thought to myself about how people are being educated so they can make informed decisions. I … Read more
Overcome a key challenge with our new test for nicotine use.
Psychemedics Test for Fentanyl Detection Cleared by FDA
Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, MA, April 24, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s first and only FDA-cleared hair test for Fentanyl, a major killer increasingly found in illegal drugs. According to … Read more
Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend
Acton, MA, April 23, 2019 — Psychemedics Corporation (NASDAQ:PMD) today announced first-quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of May 7, 2019, to be paid on May 17, 2019. This will be the Company’s 91st … Read more
New Psychemedics Offering Further Enhances Cocaine Detection
Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader in detecting drugs of abuse using hair analysis, today at the National Drug and Alcohol Screening Association (NDASA) Conference introduced the industry’s first confirmation process to accurately measure … Read more